← Back to headlines
Jefferies Highlights Iovance Biotherapeutics' Amtagvi Drug
Jefferies has drawn attention to Iovance Biotherapeutics Inc. and its Amtagvi drug, indicating potential interest or developments in the biopharmaceutical sector.
22 Apr, 11:25 — 22 Apr, 11:25
Sources
Showing 1 of 1 sources
